Loading clinical trials...
Loading clinical trials...
Use of APT™ T3X to Decrease the COVID-19 Contamination Rate in Humans
Conditions
Interventions
Tetracycline hydrochloride 3%
Placebo
Locations
1
Brazil
Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Start Date
January 28, 2021
Primary Completion Date
March 25, 2021
Completion Date
March 25, 2021
Last Updated
April 8, 2021
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
University of Nove de Julho
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions